According to a research report published by Spherical Insights & Consulting, The Germany Continuous Bioprocessing Market Size is anticipated to reach USD 160.76 Million by 2035, Growing at a CAGR of 18.63% from 2025 to 2035. The increasing need for scalable and affordable biopharmaceutical manufacturing, especially for monoclonal antibodies, vaccines, and cell and gene therapies, is what propels the sector.